Newfeed

SAN DIEGO, Dec. 12, 2023 /PRNewswire/ — ChemDiv Inc., dedicated to partnering in discovery and development of breakthrough therapies based on its unique chem-bio platforms, announces the presentation of non-clinical summary data for the best-in-class selective FLT3 clinical candidate at the 6

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: